maybe the market does not like the incompetence of the management. Almost nothing has been done since Covid 19. Ng bio is an old partner, who applied CE mark for the test, and ordered more kits from At1. But, that's all the work done by NG bio. On the contract, AT1 still not get TGA approval, and now Australia has already make the virus under control. And the negotiation with two US company are always in the cloud. now US is getting better as well, and many big med device companies has increased their capacity dramatically, and leave very little room for new entrance.
I think AT1 may have miss the lifetime opportunity, its time to leave. However, AT1 is still doing well for HIV test. I might consider re entry at low 20.
maybe the market does not like the incompetence of the...
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $19.81M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.1¢ | 2.9¢ | $4.745K | 159.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 123968 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 53324 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.1¢ |
Change
0.001 ( 3.33 %) |
||||
| Open | High | Low | Volume | ||
| 3.0¢ | 3.1¢ | 2.9¢ | 32795 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| AT1 (ASX) Chart |